STD AAPPS Supplemental Funding for Enhanced Congenital Syphilis Response

The CDC, National Center for HIV, Hepatitis, STD, and TB Prevention, Division of STD Prevention (DSTDP) has developed this 15 month supplemental FOA titled “Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development, and Prevention Strategies (STD AAPPS) Supplemental Funding for Enhanced Congenital Syphilis Response” to strengthen capacity to address congenital syphilis in the United States and build upon activities supported under CDC-RFA-PS14-1402 titled, Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development,...

Eligibility for this expansion supplement is limited to current awardees of CDC-RFA-PS14-1402 “Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy, and Prevention Strategies” (STD AAPPS). Current awardees of STD AAPPS include 59 states, territories, and city health departments. Eligibility for STD AAPPS was limited to those 59 entities, based on existing public health infrastructure and STD epidemiology. The limited eligibility memo for STD AAPPS was approved on January 8, 2013. In order to accomplish the supplemental award project objectives, the funded entity must have had 14 or more babies born with congenital syphilis reported to CDC in 2015.

Jennifer Fuld ngt0@cdc.gov